ANI Pharmaceuticals (ANIP) Stock Forecast & Price Target

ANIP$71.44+0.38 +0.53%
Drug Manufacturers - Specialty & GenericValue StockGrowth StockHigh Quality
Compare
Market cap$1.62BEnterprise value$1.42BRevenue (TTM)$1.04BMarket position—

Score

75
Bullish
Value
76
Quality
73
Growth
76

ANI Pharmaceuticals, Inc. price target

ANIP
Low$85.00
Average$99.50
High$119.00
Upside vs current price+39.3%

The average target of $99.50 is +39.3% versus the current ANIP price of $71.44.

ANI Pharmaceuticals, Inc. analyst ratings

RatingAnalysts
Strong buy3
Buy4
Hold2
Sell0
Strong sell0
ConsensusBuy

9 analysts cover ANIP.

ANI Pharmaceuticals, Inc. EPS and revenue estimates

Published annual figures for ANIP on this page are 2026 EPS $9.26, 2027 EPS $10.13. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$9.26$1.10B
2027$10.13$1.22B

Is ANI Pharmaceuticals, Inc. a buy or sell?

Of the 9 analysts covering ANI Pharmaceuticals, Inc., 7 rate it a buy (3 strong buy and 4 buy), 2 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The ANIP consensus label is Buy, beside 7 buy-side ratings and 0 sell-side ratings.

The average target of $99.50 implies +39.3% versus the current price of $71.44.

The ANIP rating block is 9 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the ANI Pharmaceuticals, Inc. forecast

the ANI Pharmaceuticals, Inc. is priced by the street between $85.00 and $119.00, average $99.50.

The gap from the $71.44 price to the ANIP average is +39.3%.

The ANIP rating mix is lopsided rather than split: 7 of 9 analysts are on the buy side, 2 are at hold, and 0 are on the sell side, and the published consensus is Buy.

the ANI Pharmaceuticals, Inc. has a rising EPS path, $9.26 for 2026 and $10.13 for 2027.

With 9 analysts on ANIP, the average is a small sample.

ANI Pharmaceuticals, Inc. forecast questions

What is the ANIP price target?

The published range for ANIP is $85.00 to $119.00, with an average of $99.50. That average is +39.3% versus the current price of $71.44.

Is ANI Pharmaceuticals, Inc. a buy or sell?

Of the 9 analysts covering ANI Pharmaceuticals, Inc., 7 rate it a buy, 2 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving ANIP at 7 buy ratings, 2 holds, and 0 sells.

What is the EPS estimate for ANI Pharmaceuticals, Inc.?

Analyst EPS estimates for ANI Pharmaceuticals, Inc.: 2026 $9.26, 2027 $10.13.

What is the revenue estimate for ANI Pharmaceuticals, Inc.?

Analyst revenue estimates for ANI Pharmaceuticals, Inc.: 2026 $1.10B, 2027 $1.22B.

How many analysts cover ANIP?

9 analysts cover ANIP. Their consensus on ANIP is Buy, across those 9.

ANIP price $71.44 +0.38 +0.53%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener